ROCHE HOLDING AG

Press Releases Roche Holding AG Swiss Exchange

Stocks

RO

CH0012032113

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 09:00:08 11/06/2026 pm IST			5-day change	1st Jan Change
330.80 ^CHF	+0.24%		0.00%	-1.31%

08:33pm	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
08:33pm	Race to launch weight-loss pill heats up as Novo wins UK approval	RE

Press Releases

10:36am	FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer	BU
04/06	Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection	PR
02/06	FDA Accepts New Drug Application for Genentech’s Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting	BU
01/06	Genentech to Present New Data Advancing Its Obesity Portfolio at the American Diabetes Association’s 2026 Scientific Sessions	BU
19/05	Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant's Potential to Transform the Treatment Paradigm in Early Breast Cancer	BU
15/05	FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment	BU
30/04	Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026	BU
24/04	Genentech Partners With Comedy Icon Damon Wayans and diaTribe to Address Diabetes-Related Vision Loss With ‘All Eyes on DME’ Campaign	BU
22/04	Roche's ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD	AQ
22/04	Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS	BU
21/04	Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for MOGAD	BU
21/04	CORRECTING and REPLACING FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus	BU

No results match your criteria

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Roche Holding: An assuring start to the year

Roche Holding: An assuring start to the year

April 23, 2026 at 07:02 pm IST

The Price of Patience

April 23, 2026 at 02:47 pm IST

The Price of Patience

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!